Combining Biocatalysts and Semi-Synthesis to (Bio) Synthesize Recalcitrant Pharmaceuticals
Archives in Biomedical Engineering & Biotechnology · 2019
DOI: 10.33552/abeb.2019.01.000519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives in Biomedical Engineering & Biotechnology, 2019. Verfasst von Nik Kovinich. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Difficult-to-synthesize (recalcitrant) bioactive molecules can be (bio)synthesized using semi-synthesis and biocatalysis methods in tandem.Biocatalysts modules consist of promiscuous enzymes heterologously expressed in microbes that can accept semi-synthetic versions of natural products.
Zitieren
APA
Kovinich, N. (2019). Combining Biocatalysts and Semi-Synthesis to (Bio) Synthesize Recalcitrant Pharmaceuticals. Archives in Biomedical Engineering & Biotechnology. https://doi.org/10.33552/abeb.2019.01.000519
Vancouver
Kovinich N. Combining Biocatalysts and Semi-Synthesis to (Bio) Synthesize Recalcitrant Pharmaceuticals. Archives in Biomedical Engineering & Biotechnology. 2019. doi:10.33552/abeb.2019.01.000519
BibTeX
@article{Kovinich2019,
author = {Kovinich, Nik},
title = {Combining Biocatalysts and Semi-Synthesis to (Bio) Synthesize Recalcitrant Pharmaceuticals},
journal = {Archives in Biomedical Engineering & Biotechnology},
year = {2019},
doi = {10.33552/abeb.2019.01.000519}
}
EUVIMED